FinDec Wealth Services’s Cardiff Oncology CRDF Stock Holding History

FinDec Wealth Services’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.9K	Hold	16,000	–	–	0.03%	30
2025 Q4	$45K	Hold	16,000	–	–	0.05%	32
2025 Q3	$33K	Hold	16,000	–	–	0.03%	34
2025 Q2	$50.4K	Hold	16,000	–	–	0.05%	35
2025 Q1	$50.2K	Hold	16,000	–	–	0.05%	38
2024 Q4	$69.4K	Hold	16,000	–	–	0.05%	39
2024 Q3	$42.7K	Hold	16,000	–	–	0.02%	42
2024 Q2	$35.5K	Hold	16,000	–	–	0.02%	41
2024 Q1	$85.4K	Hold	16,000	–	–	0.05%	43
2023 Q4	$23.7K	Hold	16,000	–	–	0.02%	43
2023 Q3	$22.2K	Hold	16,000	–	–	0.02%	43
2023 Q2	$23.5K	Hold	16,000	–	–	0.02%	44
2023 Q1	$26.4K	Hold	16,000	–	–	0.02%	42
2022 Q4	$22.4K	Buy	+16,000	New	+$22.9K	0.02%	40

Other funds holding CRDF

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

FLPIM

F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

FinDec Wealth Services's CRDF Position: Q1 2026 in Review

FinDec Wealth Services held its Cardiff Oncology (CRDF) position steady in Q1 2026 at 16,000 shares worth $25.9K. The position accounts for 0.03% of the portfolio, ranked #30.

FinDec Wealth Services first reported a position in CRDF in Q4 2022 and has held it in 14 quarters since. The position peaked at $85.4K in Q1 2024. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

FinDec Wealth Services held 16,000 shares of Cardiff Oncology worth $25.9K as of Q1 2026.
FinDec Wealth Services left its Cardiff Oncology share count unchanged in Q1 2026.
Cardiff Oncology made up 0.03% of FinDec Wealth Services's portfolio in Q1 2026, its #30 holding.
FinDec Wealth Services first reported a position in Cardiff Oncology in Q4 2022 and has held it in 14 quarters since.
FinDec Wealth Services's Cardiff Oncology position peaked at $85.4K in Q1 2024.
116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on FinDec Wealth Services's 13F filing for Q1 2026, filed 5 May 2026.